Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial Investigating Acute Local Toxicities of Intraoperative Radiotherapy as a Boost Dose in Korean Breast Cancer Patients Undergoing Breast Conserving Surgery

NCT02213991 is registered in ClinicalTrials.gov with Gangnam Severance Hospital as lead sponsor.

NCT NCT02213991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02213991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial Investigating Acute Local Toxicities of Intraoperative Radiotherapy as a Boost Dose in Korean Breast Cancer Patients Undergoing Breast Conserving Surgery
Lead sponsor
Gangnam Severance Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
August 31, 2014
Completion date
March 31, 2020
Enrollment
215 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer